First Light Asset Management, LLC
- SEC CIK
- 0001600004
- Latest filing
- Aug 14, 2026
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 44
- −6 vs. Q1 2024
- Portfolio value
- $1.14B
- −$165.4M (−12.7%) vs. Q1 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| FNAParagon 28, Inc. | COM | 8,174,832 | $55.9M | 4.9% | +4,371,864+115.0% | Added | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 5,327,978 | $55.7M | 4.9% | −90,653−1.7% | Reduced | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 1,200,508 | $53.8M | 4.7% | −489,669−29.0% | Reduced | History |
| NEONeogenomics Inc | COM NEW | 3,782,561 | $52.5M | 4.6% | +480,396+14.5% | Added | History |
| XENEXenon Pharmaceuticals Inc. | COM | 1,306,260 | $50.9M | 4.5% | −13,912−1.1% | Reduced | History |
| TMDXTransMedics Group, Inc. | COM | 300,600 | $45.3M | 4.0% | −411,082−57.8% | Reduced | History |
| ATRCAtriCure, Inc. | COM | 1,964,703 | $44.7M | 3.9% | +581,843+42.1% | Added | History |
| PODDInsulet Corp | Stock | 215,637 | $43.5M | 3.8% | +64,373+42.6% | Added | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 4,780,560 | $43.2M | 3.8% | +1,778,515+59.2% | Added | History |
| NTRANatera, Inc. | COM | 369,068 | $40.0M | 3.5% | −287,640−43.8% | Reduced | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 963,146 | $39.6M | 3.5% | +172,700+21.8% | Added | History |
| LIVNLivaNova PLC | SHS | 710,390 | $38.9M | 3.4% | +607,598+591.1% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 551,303 | $36.9M | 3.2% | +268,537+95.0% | Added | History |
| PLRXPliant Therapeutics, Inc. | COM | 3,401,213 | $36.6M | 3.2% | −133,780−3.8% | Reduced | History |
| VERAVera Therapeutics, Inc. | CL A | 1,005,723 | $36.4M | 3.2% | +569,590+130.6% | Added | History |
| SIBNSI-BONE, Inc. | COM | 2,473,289 | $32.0M | 2.8% | +1240.0% | Added | History |
| RCMR1 RCM Inc. | COM | 2,464,809 | $31.0M | 2.7% | −87,516−3.4% | Reduced | History |
| PHLTPerformant Healthcare Inc | COM | 10,514,200 | $30.5M | 2.7% | −9270.0% | Reduced | History |
| OSCROscar Health, Inc. | CL A | 1,865,922 | $29.5M | 2.6% | −236,632−11.3% | Reduced | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 708,482 | $28.5M | 2.5% | +233,405+49.1% | Added | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 1,384,768 | $28.0M | 2.5% | +191,717+16.1% | Added | History |
| EVHEvolent Health, Inc. | CL A | 1,445,305 | $27.6M | 2.4% | +1,157,124+401.5% | Added | History |
| HCATHealth Catalyst, Inc. | COM | 3,956,089 | $25.3M | 2.2% | +3,221,408+438.5% | Added | History |
| AXGNAxogen, Inc. | COM | 3,344,033 | $24.2M | 2.1% | +2,578,147+336.6% | Added | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 590,647 | $23.2M | 2.0% | +441,534+296.1% | Added | History |
| NARIInari Medical, Inc. | Stock | 472,384 | $22.7M | 2.0% | +258,444+120.8% | Added | History |
| ANABAnaptysbio, Inc | COM | 779,158 | $19.5M | 1.7% | −164,952−17.5% | Reduced | History |
| OPRXOptimizeRx Corp | COM NEW | 1,826,961 | $18.3M | 1.6% | +89,377+5.1% | Added | History |
| TCMDTactile Systems Technology Inc | COM | 1,338,902 | $16.0M | 1.4% | −1,303,073−49.3% | Reduced | History |
| DYNDyne Therapeutics, Inc. | COM | 382,433 | $13.5M | 1.2% | +276,485+261.0% | Added | History |
| KRMDKORU Medical Systems, Inc. | COM | 5,038,387 | $13.4M | 1.2% | −182,603−3.5% | Reduced | History |
| AVTRAvantor, Inc. | COM | 596,124 | $12.6M | 1.1% | −254,571−29.9% | Reduced | History |
| GHGuardant Health, Inc. | COM | 416,967 | $12.0M | 1.1% | +227,202+119.7% | Added | History |
| PCVXVaxcyte, Inc. | COM | 139,729 | $10.6M | 0.9% | +79,445+131.8% | Added | History |
| SVRASavara Inc | COM | 2,002,219 | $8.07M | 0.7% | +2,002,219 | New | History |
| PENPenumbra Inc | COM | 43,108 | $7.76M | 0.7% | +5,153+13.6% | Added | History |
| HUMHumana Inc | Stock | 16,139 | $6.03M | 0.5% | +16,139 | New | History |
| CNCCentene Corp | Stock | 88,827 | $5.89M | 0.5% | +88,827 | New | History |
| EXASExact Sciences Corp | COM | 125,386 | $5.30M | 0.5% | +125,386 | New | History |
| STVNStevanato Group S.p.A. | ORD SHS | 272,833 | $5.00M | 0.4% | −563,152−67.4% | Reduced | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 36,157 | $4.93M | 0.4% | +36,157 | New | History |
| INSPInspire Medical Systems, Inc. | COM | 28,135 | $3.77M | 0.3% | −111,816−79.9% | Reduced | History |
| SLPSimulations Plus, Inc. | COM | 28,259 | $1.37M | 0.1% | −482−1.7% | Reduced | History |
| SONXSonendo, Inc. | COM | 5,143,615 | $349.8K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q1 2024 (11)
Positions held at the end of Q1 2024 that are gone from this filing.
| Security | Class | Shares in Q1 2024 | Value in Q1 2024 | % of portfolio in Q1 2024 | History |
|---|---|---|---|---|---|
| SWAVShockwave Medical, Inc. | COM | 161,484 | $52.6M | 4.0% | History |
| IRTCiRhythm Holdings, Inc. | COM | 420,892 | $48.8M | 3.7% | History |
| MODNModel N, Inc. | COM | 894,241 | $25.5M | 1.9% | History |
| PRVAPrivia Health Group, Inc. | COM | 1,103,601 | $21.6M | 1.7% | History |
| SCTLSocietal CDMO, Inc. | COM | 19,676,396 | $21.3M | 1.6% | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 501,243 | $19.9M | 1.5% | History |
| TELATELA Bio, Inc. | COM | 2,754,028 | $15.6M | 1.2% | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 335,471 | $14.7M | 1.1% | History |
| PRTAProthena Corp Public Ltd Co | SHS | 444,953 | $11.0M | 0.8% | History |
| THCTenet Healthcare Corp | COM NEW | 79,523 | $8.36M | 0.6% | History |
| VTYXVentyx Biosciences, Inc. | COM | 624,842 | $3.44M | 0.3% | History |